Maravai LifeSciences (NASDAQ:MRVI) reported its Q3 earnings results on Tuesday, November 7, 2023 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
Maravai LifeSciences missed estimated earnings by 200.0%, reporting an EPS of $-0.01 versus an estimate of $0.01.
Revenue was down $124.40 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.01 which was followed by a 0.73% increase in the share price the next day.
Here’s a look at Maravai LifeSciences’s past performance:
| Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|
| EPS Estimate | 0.01 | 0.04 | 0.34 | 0.33 |
| EPS Actual | 0 | 0.03 | 0.35 | 0.37 |
| Revenue Estimate | 70.30M | 79.72M | 204.93M | 195.10M |
| Revenue Actual | 68.91M | 79.03M | 204.71M | 191.26M |
To track all earnings releases for Maravai LifeSciences visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
